Effects of a Large Language Model-Driven Chatbot on Reproductive Concerns After Cancer
The Feasibility and Preliminary Effectiveness of a Large Language Model-Driven Chatbot in Addressing Reproductive Concerns Among Adolescent and Young Adult Cancer Survivors: A Pilot Randomized Controlled Trial
1 other identifier
interventional
60
2 countries
2
Brief Summary
Reproductive health has emerged as a critical yet overlooked concern among Adolescent and Young Adult (AYA) cancer survivors, given their compromised potential for biological parenthood in prime childbearing years. Large language models (LLMs) offer a promising solution to bridge onco-fertility service gaps by integrating evidence-based knowledge and therapeutic frameworks. This pilot randomized controlled trial aims to assess the feasibility and preliminary effectiveness of an LLM-driven chatbot versus electronic brochure in addressing reproductive concerns among AYA cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
Study Completion
Last participant's last visit for all outcomes
June 30, 2027
August 3, 2026
July 1, 2026
10 months
July 28, 2026
July 28, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Total interaction time
The cumulative time spent interacting with the chatbot or reading the electronic brochure during the study period.
At 4 weeks, 8 weeks
Number of active days
The total number of distinct days on which a participant actively engaged with the chatbot or accessed the electronic brochure.
At 4 weeks, 8 weeks
Dropout rate
The proportion of randomized participants who do not complete the intervention or outcome measures.
At 4 weeks, 8 weeks
Secondary Outcomes (5)
Reproductive concerns
At baseline, 4 weeks, 8 weeks
Psychological flexibility
At baseline, 4 weeks, 8 weeks
Depression
At baseline, 4 weeks, 8 weeks
Life quality
At baseline, 4 weeks, 8 weeks
Decisional conflict
At baseline, 4 weeks, 8 weeks
Study Arms (2)
Chatbot
EXPERIMENTALElectronic brochure
ACTIVE COMPARATORInterventions
A large language model-driven chatbot that incorporates acceptance and commitment therapy, a verified onco-fertility knowledge base, and relevant policy information.
An electronic brochure that contains psychoeducational materials, verified onco-fertility knowledge, and relevant policy information.
Eligibility Criteria
You may qualify if:
- (1) 15-39-year-old females; (2) cancer diagnosis between ages 15-39; (3) current or prior concerns regarding fertility; (4) proficiency in Mandarin Chinese; and (5) access to a mobile device for intervention delivery.
You may not qualify if:
- (1) Involvement in the chatbot co-design phases; (2) inability to provide informed consent; (3) significant sensory, cognitive, or psychological impairments precluding meaningful participation; and (4) acute illness at the time of recruitment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The University of Science and Technology of China
Hefei, Anhui, 230026, China
The Hong Kong Polytechnic University
Kowloon, Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2026
First Posted
August 3, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share